XML 85 R44.htm IDEA: XBRL DOCUMENT v3.3.1.900
Pharmacies and Clinics Transactions (Tables)
 12 Months Ended
Jan. 30, 2016
Discontinued Operations and Disposal Groups [Abstract]  
Schedule of Gain on Pharmacies and Clinics Transaction
Gain on Pharmacies and Clinics Transaction
(millions)
2015

Cash consideration
$
1,868

Less:
 
Deferred income (a)
694

Inventory
447

Other assets
13

Pretax transaction costs and contingent liabilities (b)
94

Pretax gain on pharmacies and clinics transaction (c)
$
620

(a) 
Represents deferred income that will be recorded as a reduction to SG&A expense evenly over the 23-year weighted average remaining accounting useful life of our stores. As of January 30, 2016, $690 million remains in other current and other noncurrent liabilities.
(b) 
Primarily relates to professional services, contract termination charges, severance, and impairment of certain assets not sold to CVS.
(c) 
Recorded outside of segment results and excluded from Adjusted EPS.
Income / (Loss) on Discontinued Operations
(millions)
2015

2014

2013

Sales
$
—

$
1,902

$
1,317

Cost of sales
—

1,541

1,121

SG&A expenses 
—

909

910

Depreciation and amortization
—

248

227

Interest expense
—

73

77

Pretax loss from operations
—

(869
)
(1,018
)
Pretax exit costs
(129
)
(5,105
)
—

Income taxes
171

1,889

295

Income / (loss) from discontinued operations
$
42

$
(4,085
)
$
(723
)
Schedule of Pharmacy and Clinic Inventory and Other Assets
The pharmacy and clinic inventory and other assets sold had the following balances as of January 31, 2015:


(millions)
 
January 31,
2015

Inventory included in other current assets
 
$
508

Other current assets
 
2

Other noncurrent assets
 
12

Total
 
$
522